UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
SCHEDULE l3D
Under the Securities Exchange Act of 1934
(Amendment No. 9)*
KINDRED HEALTHCARE, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.25 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
494580103
--------------------------------------------------------------------------------
(CUSIP Number)
with a copy to:
Stephen Feinberg Robert G. Minion, Esq.
299 Park Avenue Lowenstein Sandler PC
22nd Floor 65 Livingston Avenue
New York, New York 10171 Roseland, New Jersey 07068
(212) 421-2600 (973) 597-2424
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 5, 2004
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Cusip No. 494580103
--------------------------------------------------------------------------------
1) Names of Reporting Persons. I.R.S. Identification Nos. of above persons
(entities only):
Stephen Feinberg
--------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions):
(a) Not
(b) Applicable
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Source of Funds (See Instructions): WC
--------------------------------------------------------------------------------
5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e): Not Applicable
--------------------------------------------------------------------------------
6) Citizenship or Place of Organization: United States
--------------------------------------------------------------------------------
Number of 7) Sole Voting Power: *
------------------------------------
Shares Beneficially 8) Shared Voting Power: *
------------------------------------
Owned by
Each Reporting 9) Sole Dispositive Power: *
------------------------------------
Person With 10) Shared Dispositive Power: *
------------------------------------
--------------------------------------------------------------------------------
11) Aggregate Amount Beneficially Owned by Each Reporting Person: 850,000*
--------------------------------------------------------------------------------
12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions): Not Applicable
--------------------------------------------------------------------------------
13) Percent of Class Represented by Amount in Row (11): 4.7%*
--------------------------------------------------------------------------------
14) Type of Reporting Person (See Instructions): IA, IN
--------------------------------------------------------------------------------
* Cerberus Partners, L.P., a Delaware limited partnership ("Cerberus"), is the
holder of 10,710 shares of the common stock, par value $0.25 per share (the
"Shares"), of Kindred Healthcare, Inc. (the "Company"), Cerberus Institutional
Partners, L.P., a Delaware limited partnership ("Institutional"), is the holder
of 154,889 Shares, Cerberus International, Ltd., a corporation organized under
the laws of the Bahamas ("International"), is the holder of 455,120 Shares and
various other private investment funds (the "Funds") own in the aggregate
229,281 Shares. Stephen Feinberg possesses sole power to vote and direct the
disposition of all securities of the Company owned by each of Cerberus,
Institutional, International and the Funds. Thus, as of May 5, 2004, for the
purposes of Reg. Section 240.13d-3, Stephen Feinberg is deemed to beneficially
own 850,000 Shares, or 4.7% of the Shares deemed issued and outstanding as of
that date. See Item 5 of this Amendment No. 9 to Schedule 13D for further
information.
Item 5. Interest in Securities of the Issuer.
------------------------------------
Based upon the Company's Definitive Proxy Statement pursuant to
Section 14(a) of the Securities Exchange Act of 1934 filed on March 29, 2004, as
of March 25, 2004 there were 18,183,712 Shares issued and outstanding. As of
May 5, 2004, Cerberus is the holder of 10,710 Shares, Institutional is the
holder of 154,889 Shares, International is the holder of 455,120 Shares and the
Funds in the aggregate hold 229,281 Shares. Mr. Feinberg possesses sole power
to vote and direct the disposition of all securities of the Company owned by
each of Cerberus, Institutional, International and the Funds. Thus, as of May 5,
2004, for the purposes of Reg. Section 240.13d-3, Stephen Feinberg is deemed to
beneficially own 850,000 Shares, or 4.7% of the Shares deemed issued and
outstanding as of that date.
Stephen Feinberg ceased to be the beneficial owner of more than 5% of
the Shares deemed to be outstanding as of May 3, 2004.
The following table details the transactions since the filing of the
Schedule 13D Amendment No. 8 dated as of February 4, 2004 by Mr. Feinberg in
Shares, or securities convertible into, exercisable for or exchangeable for
Shares, by Mr. Feinberg or any other person or entity controlled by him or any
person or entity for which he possesses voting or investment control over the
securities thereof (each of which were effected in an ordinary brokerage
transaction):
I. Cerberus
-----------
(Purchases)
NONE
(Sales)
Date Quantity Price
---- -------- -----
April 30, 2004 1,000 $48.77
May 3, 2004 580 $49.52
May 4, 2004 300 $49.76
May 5, 2004 300 $51.18
II. Institutional
-----------------
(Purchases)
NONE
(Sales)
Date Quantity Price
---- -------- -----
April 30, 2004 13,800 $48.77
May 3, 2004 8,530 $49.52
May 4, 2004 4,550 $49.76
May 5, 2004 4,550 $51.18
III. International
------------------
(Purchases)
NONE
(Sales)
Date Quantity Price
---- -------- -----
April 30, 2004 40,000 $48.77
May 3, 2004 25,240 $49.52
May 4, 2004 3,000 $49.44
May 4, 2004 13,400 $49.76
May 5, 2004 13,400 $51.18
IV. The Funds
-------------
(Purchases)
NONE
(Sales)
Date Quantity Price
---- -------- -----
April 30, 2004 20,200 $48.77
May 3, 2004 12,650 $49.52
May 4, 2004 6,750 $49.76
May 5, 2004 6,750 $51.18
Signature
---------
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
November 16, 2004
/s/ Stephen Feinberg
--------------------------------------
Stephen Feinberg, in his capacity
as the managing member of Cerberus
Associates, L.L.C., the general
partner of Cerberus Partners, L.P.,
and the investment manager for
Cerberus Institutional Partners, L.P.,
Cerberus International, Ltd. and the
Funds
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001).